YY/T 1729-2020 “Fungus (1-3)-β-D-Glucan Test” formulated by Era Biology was approved by NMPA on July 9, 2020 and officially released. The standard will be formally implemented on June 1...
A recent multi-center study on the diagnosis of cryptococcal infections was conducted by the Medical Center of Utrecht University, the Institute of Biodiversity and Ecosystem Dynamics of the Univer...
ERA BIOLOGY Great Show at Africa Health 2022
Gallagher Convention Center, Johannesburg, South Africa – 26th-28th October – ERA BIOLOGY participated in Africa Health 2022, which is the most influent...
Tianjin, China – March 18, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a lead and pioneer of invasive fungal disease diagnostic field since 1997...
Meeting Era Biology at AACC 2023
The AACC congress, the American Association for Clinical Chemistry, is the premier global gathering for laboratory medicine professionals. This year, it will take p...
Invasive candidiasis is a frequent life-threatening complication in critically ill patients. Early diagnosis followed by prompt treatment aimed at improving outcome by minimizing unnecessary antifu...